tiprankstipranks
Trending News
More News >

RedHill Biopharma Announces Agenda for 2025 Annual General Meeting

Story Highlights
RedHill Biopharma Announces Agenda for 2025 Annual General Meeting

Don’t Miss TipRanks’ Half-Year Sale

RedHill Biopharma ( (RDHL) ) has provided an update.

RedHill Biopharma Ltd. has announced its upcoming Annual General Meeting of Shareholders, scheduled for May 5, 2025, in Tel Aviv, Israel. Key agenda items include the appointment of Kesselman & Kesselman as auditors, the re-election of board members, approval of a renewed compensation policy, and the granting of restricted share units to key executives and directors. These proposals are aimed at strengthening the company’s governance and aligning executive incentives with shareholder interests.

More about RedHill Biopharma

RedHill Biopharma Ltd. is a biopharmaceutical company based in Tel Aviv, Israel. The company focuses on the development and commercialization of late clinical-stage, proprietary, and orally-administered drugs for the treatment of gastrointestinal and infectious diseases.

YTD Price Performance: -58.44%

Average Trading Volume: 90,512

Technical Sentiment Signal: Buy

Current Market Cap: $3.39M

Learn more about RDHL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1